Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Insider

EIKN

Eikon Therapeutics Inc

Feb 09 • 10:44AM ET

15.05

+0.55 3.76 %

Healthcare • Biotechnology • USA • NASD

Feb 06, 4:20 PMEikon Therapeutics discloses that it has amended its certificate of incorporation and bylaws today in connection with the closing of its IPO.

Held by: TMED BMED

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	50.45M	Perf Week	-
Market Cap	759.02M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	18.77M	Perf Month	-
Enterprise Value	1.55B	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	0.30%
Book/sh	-11.34	P/C	3.44	EPS next 5Y	-	ROE	-	52W High	17.40 -13.53%	Perf Year	-
Cash/sh	4.37	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	13.75 9.42%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	- -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	2.38	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.04	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	4.04	EPS Q/Q	-	SMA20	1.32%	Beta	-	Target Price	-
Payout	-	Debt/Eq	0.86	Sales Q/Q	-	SMA50	1.32%	Rel Volume	0.15	Prev Close	14.50
Employees	-	LT Debt/Eq	0.82	Earnings	-	SMA200	1.32%	Avg Volume	2.87M	Price	15.05
IPO	Feb 05, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	98,144	Change	3.76%

Today 08:30AM	Wall Street Braces For IPO Boom: Goldman Says 2026 Listings Could Hit $160 Billion As Tech, AI Lead (Benzinga)
Feb-06-26 04:18PM	Jennifer Garner's Once Upon a Farm Rises Nearly 20% To Wrap Up Busy Week for IPOs (Barrons.com)
Feb-05-26 07:23PM	This Mobile App Marketing Firm Is Holding Off an IPO for Now (Barrons.com)
Feb-04-26 07:59PM	Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering (GlobeNewswire)

Eikon Therapeutics is a biopharmaceutical company. It engages in the development of medicines for unmet medical needs. The company was founded in 2019 and is headquartered in Millbrae, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Foresite Capital Management IV	10% Owner	Feb 04 '26	Buy	18.00	55,555	999,990	1,318,983	Feb 06 07:37 PM
FRAZIER KENNETH C	Director	Feb 04 '26	Buy	18.00	111,111	1,999,998	111,111	Feb 06 06:33 PM
Wolfe Josh	Director	Feb 04 '26	Buy	18.00	277,776	4,999,968	138,888	Feb 06 06:27 PM
Lux Venture Partners V, LLC	10% Owner	Feb 04 '26	Buy	18.00	277,776	4,999,968	138,888	Feb 06 06:25 PM

EIKN

Eikon Therapeutics Inc

Upgrade your FINVIZ experience